Noetik co-founders: CEO Ron Alfa (L) and CSO Jacob Rinaldi
September 7, 2023 06:30 AM EDT
Financing
Startups

Ex­clu­sive: Two ex-Re­cur­sion lead­ers start Noetik in a bid to fix the bro­ken fun­nel in can­cer drug re­search

Andrew Dunn

Senior Biopharma Correspondent

Two for­mer lead­ers of Re­cur­sion Phar­ma­ceu­ti­cals have start­ed their own biotech start­up, hop­ing to bring a sim­i­lar da­ta-ob­sessed men­tal­i­ty to can­cer re­search.

The San Fran­cis­co …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times